You are here:

  1. Home
  2. NICE Guidance
  3. NICE Advice
  4. Evidence summaries

Hyperhidrosis: oxybutynin

  • Evidence summary
  • Reference number: ES10
  • Published:  21 March 2017

Download (PDF)
  • Key points
  • Introduction and current guidance
  • Product overview
  • Evidence review
  • Estimated impact for the NHS
  • Information for the public about medicines
  • Relevance to other NICE programmes
  • References
  • Evidence tables
  • Results tables
  • Excluded studies
  • Terms used in this evidence summary
  • Search strategy
  • Development of this evidence summary

Relevance to other NICE programmes

The use of oxybutynin for hyperhidrosis is not appropriate for referral for a NICE technology appraisal and is not currently planned into any other work programme.

NICE has issued guidance on endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limb.

NICE has not issued any clinical guidelines on managing hyperhidrosis but has published the following advice relating to this condition:

  • Hyperhidrosis: oral glycopyrronium bromide.


Next page References Previous page Information for the public about medicines
Back to top